Prame Positive clinical trials

Explore recruiting prame positive clinical trials.

Recruiting prame positive studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Prame Positive trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 1 Study of IMC-P115C in Advanced PRAME Positive Cancers

Italy, Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A study testing a new treatment called TK-6302 for the first time in people with advanced cancers that have a genetic marker called HLA-A02:01 and a tumour protein called PRAME.

Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Prame Positive trials by city

Prame Positive in Toronto Prame Positive in Vancouver Prame Positive in Montreal Prame Positive in Calgary Prame Positive in Edmonton Prame Positive in Ottawa Prame Positive in Winnipeg Prame Positive in Quebec City Prame Positive in Hamilton Prame Positive in Kitchener Prame Positive in London Prame Positive in Halifax Prame Positive in New York Prame Positive in Los Angeles Prame Positive in Chicago Prame Positive in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease